- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
For CHEST 2021 and Beyond, Expect to Hear More About Cannabis, COVID-19, Chronic Lung Disease
Don Sin, MD, FRCP, MPH, who is presenting at CHEST 2021 on the topic of precision medicine and chronic obstructive pulmonary disease, discusses other topics of interest at CHEST 2021, which takes place virtually from October 17 to October 20, 2021.
Don Sin, MD, FRCP, MPH, who is presenting at CHEST 2021 on the topic of precision medicine and chronic obstructive pulmonary disease, discusses other topics of interest at CHEST 2021, which takes place virtually from October 17 to October 20, 2021. He is a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.
Transcript
Looking ahead to the CHEST 2021 meeting, are there any topics that you think are key for clinicians or researchers to attend?
I think the one that's going to come up very prominently, maybe not at this conference, but going forward, is the effect of cannabis, so, weed smoking, on lung health. In Canada, as you know, it’s completely legal, and I think many states in the US are moving towards that direction and consumption of cannabis as an inhalant has skyrocketed in North America. The full impact on lung health of cannabis smoking is certainly not known. So I think that you'll see more of that in the next few years. And obviously, with COVID, not just with COVID, but respiratory infections in general, in individuals with pre-existing chronic lung disease, is also a prominent topic of discussion and research. And even if we get out of this pandemic, which we will, I think the importance of respiratory tract infection, particularly with viruses, has been highlighted and the importance emphasized during this pandemic.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
